Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Cagrilintide

02 1Linaclotide

03 1Liraglutide

04 1Retatrutide

05 1Semaglutide

06 1Tirzepatide

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
blank

01

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Xiushi Biopharma

Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

blank
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
blank

02

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Xiushi Biopharma

Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

blank
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
blank

03

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Xiushi Biopharma

Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

blank
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
blank

04

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Xiushi Biopharma

Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

blank
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
blank

05

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Xiushi Biopharma

Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

blank
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, ...
Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.
blank

06

Pharmex
Not Confirmed
arrow
arrow
Pharmex
Not Confirmed

Xiushi Biopharma

Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production facility, we support clients from discovery to commercialization, offering scalable synthesis up to kg quantities. Our expertise spans peptide CMC development, NCEs, and generic drug manufacturing, ensuring compliance with FDA/EU GMP standards. Backed by a skilled scientific team, we deliver end-to-end solutions for peptide-based therapeutics, accelerating biopharma innovation worldwide.

About the Company : Xiushi Biopharma is a leading global CDMO specializing in peptide and oligonucleotide drug development and manufacturing. With a 5,000 sqm R&D center and 20,000 sqm GMP-compliant production faci...

blank
Contact Xiushi Biopharma and get a quotation

Xiushi Biopharma is a supplier offers 6 products (APIs, Excipients or Intermediates).

Find a price of Semaglutide bulk with DMF offered by Xiushi Biopharma

Find a price of Cagrilintide bulk offered by Xiushi Biopharma

Find a price of Linaclotide bulk offered by Xiushi Biopharma

Find a price of Liraglutide bulk offered by Xiushi Biopharma

Find a price of Retatrutide bulk offered by Xiushi Biopharma

Find a price of Tirzepatide bulk offered by Xiushi Biopharma